Siegmund Karasch
Direktor/Vorstandsmitglied bei DEUTSCHE BIOTECH INNOVATIV AG
Aktive Positionen von Siegmund Karasch
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Direktor/Vorstandsmitglied | 05.07.2018 | - |
Karriereverlauf von Siegmund Karasch
Ehemalige bekannte Positionen von Siegmund Karasch
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Direktor/Vorstandsmitglied | 01.01.2011 | 01.01.2014 |
| Gründer | - | 01.01.2014 | |
InVivo BioTech Services GmbH
 InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany. | Vorstandsvorsitzender | 01.01.2001 | - |
| Geschäftsführer | 01.01.2001 | - |
Ausbildung von Siegmund Karasch
| Hochschule für Technik und Wirtschaft Berlin | Undergraduate Degree |
Statistik
International
| Deutschland | 5 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Finance |
| Private Unternehmen | 2 |
|---|---|
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany. | Health Technology |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
- Börse
- Insiders
- Siegmund Karasch
- Erfahrung
